Allogene outlines plan for ~100 ALPHA3 sites by year end as FDA grants RMAT and Fast Track for cema-cel
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking AlphaRelated stories
Sources: Kushner, Iger to buy Lakers for $12.5B
ESPN · just now
McCarthy: Vikings' QB decision 'out of my control'
ESPN · just now
Messi back on Miami bench after father's death
ESPN · just now
✍️ Mike Clay's Playbook, Part 2
ESPN · just now
Watson tapped to start Browns' preseason opener
ESPN · just now
Source: Panthers add to TE room with Waller deal
ESPN · just now